3 unknown, 1 completed, 1 withdrawn. 5 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Unknown 3, Completed 1, Withdrawn 1 |
| Phase 2 | 3 | Unknown 3 |
Follow Uremia: new trials by email Literature Review of Uremia trials Research Report on Uremia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion D5-0.9%NS, Routine home oral rehydration - Hemolytic-Uremic Syndrome | Phase 1 | Withdrawn | University of Calgary | 2020-05-01 | 2020-11-09 | |
| A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications CCX168, Midazolam, Celecoxib - Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis | Phase 1 | Completed | Amgen | 32 | 2016-01-14 | 2023-08-22 |
| Effect of SVF Derived MSC in DCD Renal Transplantation SVFderived MSC transplantations, Basiliximab - Uremia | Phase 1 / Phase 2 | Unknown | Fuzhou General Hospital | 120 | 2014-12-01 | 2015-07-08 |
| Clonal Deletion on Living-Relative Donor Kidney Transplantation donor specific transfusion, MMF, Bortezomib, drugs added according to the immuno condition of the recipients - Renal Transplantation, Uremia | Phase 1 / Phase 2 | Unknown | Fuzhou General Hospital | 15 | 2011-03-01 | 2011-08-22 |
| Treatment of Uremic Pruritus by Olive-omega 3 Ointment application of ointment (olive-omega 3 ointment) - Uremic Pruritus | Phase 1 / Phase 2 | Unknown | Assaf-Harofeh Medical Center | 20 | 2011-10-06 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Atypical Hemolytic Uremic Syndrome (1) · Glomerulonephritis, IGA (1) · Hemolytic-Uremic Syndrome (1) · Kidney Diseases (1) · Pruritus (1)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Male Urogenital Diseases (5) · Urogenital Diseases (5) · Urologic Diseases (5) · Kidney Diseases (4) · Anemia (2) · Anemia, Hemolytic (2) · Blood Platelet Disorders (2) · Cytopenia (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Thrombocytopenia (2)
Basiliximab (1) · Bortezomib (1) · Celecoxib (1) · Itraconazole (1) · Midazolam (1) · Rifampin (1) · avacopan (1)
Fuzhou General Hospital (2) · Amgen (1) · Assaf-Harofeh Medical Center (1) · University of Calgary (1)
China (2) · Canada (1) · United States (1)
Stephen Freedman, MDCM, MSc (1) · Tan Jianming, MD, PhD (1) · Tan Jianming, MD,PhD (1)